Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective boosted by Stifel Nicolaus from $75.00 to $85.00 in a report published on Wednesday, The Fly reports. EXAS has been the topic of a number of other research reports. Raymond James downgraded Exact Sciences from an outperform rating to a market perform rating in a […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective boosted by Bank of America from $80.00 to $88.00 in a report issued on Wednesday morning, The Fly reports. Other analysts have also recently issued research reports about the company. BTIG Research cut their target price on Exact Sciences from $85.00 to $80.00 and set […]
Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, The Fly reports. They currently have $85.00 target price on the medical research company’s stock, up from their prior target price of $55.00. Other analysts have […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) General Counsel James Herriott sold 1,300 shares of Exact Sciences stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $79.85, for a total transaction of $103,805.00. Following the completion of the sale, the general counsel now directly owns 8,564 shares […]
Skandinaviska Enskilda Banken AB publ increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,289 shares of the medical research company’s stock after acquiring an additional 358 shares […]